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PrevalenceAbstract Background and aim: Prediabetes (impaired glucose tolerance or impaired fasting glu-
cose) is usually associated with a higher health risk proﬁle for cardiovascular diseases. To our
knowledge, no data about its prevalence in Egyptian patients are available. We aimed to determine
the prevalence of prediabetes among Egyptian patients who were known to be neither diabetic nor
prediabetic & referred to undergo coronary angiography.
Methods and results: The study included 1000 consecutive Egyptians in the Cairo governorate with
no previous diagnosis of diabetes nor prediabetes, who underwent coronary angiography for sus-
pected coronary artery disease. They were screened for having prediabetes with either impaired fast-
ing glucose through checking their fasting blood sugar or impaired glucose tolerance through
checking their 2 h postprandial blood sugar.
Twenty-three percent of patients had prediabetes; either isolated impaired fasting glucose, isolated
impaired glucose tolerance or both combined together. The mean age of all patients was
52.35 ± 7.02 years. 26.33% of female patients were prediabetic while 21.43% of male patients were
prediabetic. Hypertensive prediabetic patients numbered 110 and most of them were females. Body
Mass Index among prediabetic patients was higher than that among patients with normal glucose
tolerance and in females more than males. Prediabetes was more prevalent among patients with
acute coronary syndrome than among patients with chronic ischemic heart disease.
Conclusion: Prediabetes is prevalent among ischemic Egyptian patients at a considerable ratio and
should be screened for.
ª 2012 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Prediabetes is an asymptomatic condition preceding diabetes
including both Impaired Glucose Tolerance (IGT) & Impaired
Fasting Glucose (IFG) and refers to blood glucose levels high-
er than normal but not reaching the level at which diabetes is
diagnosed.1,2 IFG is deﬁned as fasting plasma glucose (FPG)
values of 100–125 mg/dl. (Normal fasting glucose level
<100 mg/dl.)2 IGT is deﬁned as 2 h postprandial plasma
Figure 1 Patient gender affection.
296 I.M. Attia et al.glucose (PPG) of 140–199 mg/dl. (Normal 2 h postprandial
glucose level <140 mg/dl.)
The progression from normal glucose tolerance to type 2
diabetes is characterized by dual defects; insulin resistance that
means decreased tissue sensitivity to insulin & insulin secretory
defects by pancreatic Beta cell dysfunction.3 The ﬁrst glucose
abnormality that is detected is a rise in the postprandial glu-
cose levels due to reduced ﬁrst-phase insulin secretion. With
time, further decline in Beta cell function leads to the elevation
of fasting glucose levels. Eventually, diabetes occurs, with
more insulin secretory loss.4
Both prediabetes & diabetes highly predispose to cardiovas-
cular alterations. Diabetes is also associated with worse out-
comes of revascularization in the form of increased instent
restenosis & increased MACE ‘‘Major Adverse Cardiac
Events’’ in percutaneous coronary intervention (PCI) & coro-
nary artery bypass grafting (CABG).Very recently fasting blood
glucose was found to be an independent risk factor for poor long
term outcome & was associated with enhanced platelet reactiv-
ity& low response to clopidogrel in patients with acute coronary
syndrome (ACS) & poor long term outcome of PCI.5
2. Aim of the work
The aim of this study was to determine the prevalence of pre-
diabetes (impaired glucose tolerance or impaired fasting glu-
cose) among patients who were known to be neither diabetic
nor prediabetic & referred to undergo coronary angiography
in Cairo governorate in Egypt.
3. Methods
The study included 1000 consecutive Egyptian non diabetic pa-
tients (no previous diagnosis of diabetes nor prediabetes) pre-
senting to the National Heart Institute cath. lab in the Cairo
governorate, from January 2010 to June 2010 with either a
new ischemic event in the form of ACS or were known chronic
ischemic heart disease (IHD) patients. They were referred for
coronary angiography that showed signiﬁcant lesions accord-
ing to ACC/AHA deﬁnitions and would be screened for hav-
ing prediabetes with either impaired fasting glucose through
checking their fasting blood sugar or impaired glucose toler-
ance through checking their 2 h postprandial blood sugar.
Patients included were referred for coronary angiography
either after an acute ischemic event or suspected to have
chronic ischemic heart disease, known to be neither diabetic
nor prediabetic and were diagnosed to have coronary artery
disease (CAD) if a signiﬁcant lesion (P50% stenosis) was pres-
ent according to ACC/AHA guidelines.
All patients were subjected to detailed medical history tak-
ing, clinical examination and ECG, laboratory analyses includ-
ing fasting blood sugar, 2 h post prandial blood sugar and
serum creatinine and coronary angiography were done on
them using the standard techniques.
All patients gave informed consent and the protocol was
approved by the institutional review committee.
3.1. Inclusion criteria
(1) Patients were referred for coronary angiography either
after acute ischemic event or suspected to have chronic
ischemic heart disease.(2) Non diabetic patients (no previous diagnosis of diabetes
or prediabetes).
(3) Patients are diagnosed as having coronary artery disease
if a signiﬁcant lesion was present(P50% stenosis).
[ACC/AHA deﬁnition of signiﬁcant coronary artery
disease].3.2. Exclusion criteria
(1) Frank diabetic patients (previously diagnosed).
(2) Individuals with normal coronaries.
4. Results
Patients were classiﬁed into 4 groups according to the results
of their FPG after fasting for 8–10 h & PPG 2 h after 75 gm
of oral glucose intake, based on 2007 ADA guidelines as group
I: Isolated IFG (FPG 100–125 mg/dl & PPG< 140 mg/dl),
group II: Isolated IGT (FPG <100 mg/dl & PPG 140–
199 mg/dl), group III: combined IFG & IGT (FPG 100–
125 mg/dl & PPG 140–199 mg/dl) & group IV: normal glucose
tolerance (FPG <100 mg/dl & PPG <140 mg/dl).
It was noticed that 23% of the included patients had predi-
abetes. Group I (IFG) included 48 patients (4.8%), group II
(IGT) included 123 patients (12.3%), group III (IFG & IGT)
included 59 patients (5.9%). The prediabetic male patients
were 146 [ 29 in group I, 72 in group II & 45 in group III ] rep-
resenting 21.43% of the total number of males (681 patients)
while prediabetic female patients were 84 [19 in group I, 51
in group II & 14 in Group III] representing 26.33% of the total
number of females (319 patients). This shows that females are
more signiﬁcantly affected by prediabetes than males (Fig. 1).
The mean age of all patients in our study was 52.35 ± 7.02.
There was no statistically signiﬁcant value of affection of a cer-
tain range of age with prediabetes nor with CAD (Fig. 2).
Patients were admitted with either a new ischemic event
(ACS) [n= 761 (76.1%)] or electively [n= 239 (23.9%)].
Prediabetics were 179 patients among the patients of the acute
group [41 in group I, 100 in group II & 38 in group III] repre-
senting 23.52% of them while they were 51 patients among the
patients of the chronic group [7 in group I, 23 in group II & 21
in group III] representing 21.34% of them. It is noticed that
prediabetes was more prevalent among patients with ACS than
among patients with chronic IHD and that was statistically
signiﬁcant (Fig. 3).
Table 1 BMI among the cases.
BMI Range Mean ± SD ANOVA
f P-Value
Group I 22.2–34.4 26.701 ± 2.657 4.783 0.03*
Group II 21.5–31.7 26.957 ± 2.025
Group III 20.5–34.3 27.877 ± 2.496
Group IV 21.3–33.8 24.096 ± 2.037
Table 2 Mean BMI among prediabetic male and female
patients.
BMI Range Mean ± SD
Males 22.3–33.5 25.602 ± 2.314
Females 20.5–34.4 27.861 ± 2.251
Table 3 Smoking among cases.
Group Smoking
Non smoker Smoker
N % N %
Group I 33 5.92 15 3.39
Group II 73 13.08 50 11.32
Group III 35 6.27 24 5.43
Group IV 417 74.73 353 79.86
Total 558 100.00 442 100.00
Chi-square v2 5.033
P-Value 0.169
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Figure 2 Patient age groups.
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I, 21.5–31.7 with a mean of 26.957 ± 2.025 in group II, 20.5–
34.3 with a mean of 26.877 ± 2.496 in group III & 21.3–33.8
with a mean of 24.096 ± 2.037 in group IV. It is noticed that
the mean BMI among patients of group IV with normal glu-
cose tolerance is lower than that of the other 3 groups of pre-
diabetes that was statistically signiﬁcant (Table 1). It was
noticed also that the mean BMI among prediabetic female pa-
tients was higher (Table 2).
Smokers were found to be 442 patients among the whole
number of patients, about 20% of them were prediabetics
[15 in group I, 50 in group II & 24 in group III] while near
80% of them had NGT [353 in group IV] with no statistical
signiﬁcance (Table 3).
Hypertensive patients were 260 among the whole number of
patients. They were 110 prediabetic patients [21 in group I, 63
in group II, 26 in group III] representing 42.31% of the whole
number of hypertensive patients & 150 in group IV represent-
ing 57.69% of the whole number of hypertensive patients with
no statistical signiﬁcance (Table 4).
5. Discussion
Diabetes and CVD often appear as the two sides of a coin: on
one side, DM has been rated as an equivalent of CAD, and
conversely, many patients with established CAD suffer from
DM or its pre-state. Categories of abnormal glucose homeo-
stasis have been deﬁned with the goal of screening for diabetesFigure 3 Prediabetes was found to be more prrisk.6 Impaired glucose tolerance (IGT) and the more recently
created category of impaired fasting glucose (IFG) identify
individuals at increased risk for developing diabetes, based
on postchallenge or fasting glucose levels, respectively. It has
been suggested that IGT and IFG are associated with varying
rates of progression to diabetes and differences in CVD risk.6
As already remarked, diabetes and pre-diabetes are painless
and remain undetected if not investigated. Screening forevalent among patients admitted with ACS.
Table 4 Hypertension among cases.
Group Hypertension
Negative Positive Total Chi-square
N % N % N % X2 P-Value
Group I 27 3.65 21 8.08 48 4.8 0.750 0.386
Group II 60 8.11 63 24.23 123 12.3 0.073 0.787
Group III 33 4.46 26 10.00 59 5.9 0.831 0.362
Group IV 620 83.78 150 57.69 770 77 93.975 0.428
Total 740 100.00 260 100.00 1000 100
Chi-square v2 2.139
P-Value 0.544
298 I.M. Attia et al.elevated glucose (pre-diabetes) is therefore important for prog-
nostic reasons.
In this study we selected patients who were known to be
neither diabetic nor prediabetic by medical history and drug
history but known to have coronary artery disease docu-
mented by coronary angiography aiming to detect the preva-
lence of prediabetes among them. We have measured fasting
blood glucose after overnight fasting for 8–10 h and 2 h post-
prandial blood glucose to diagnose IFG and IGT respectively
according to ADA 2007 criteria.
We found that 23% (n= 230) of patients included in the
study had prediabetes that was not previously diagnosed, while
77% (n= 770) of them had NGT. More than half (n= 123)
of the prediabetic patients had isolated IGT while the other
half had either isolated IFG (n= 48) or combined IFG &
IGT (n= 59).
The Euro Heart Survey on Diabetes and the Heart, a co-
hort of 4961 people from 110 centers in 25 countries across
Europe presenting with CAD, revealed that a third of the pa-
tients with acute and stable CAD were known to have DM.
When an oral glucose tolerance test (OGTT) was performed,
another 15% of acute patients and 10% of stable patients were
shown to have diabetes that was not yet recognized. Further-
more, about 25% had IFG or IGT. Thus, the majority of pa-
tients with acute or chronic CAD had an abnormal glucose
metabolism.7 A coronary event often was the ﬁrst manifesta-
tion of diabetes.7
Similar results were found in the AusDiab study, a popula-
tion-based national survey of the Australian general popula-
tion aged P25 years residing in 42 randomly selected urban
and rural areas, which revealed that among 1515 Australian
men and women, 4.2% had IFG & 10.5% had IGT in the year
2004.8
However, in the China Heart Survey aimed at characteriz-
ing the glucometabolic state of patients with CAD in China,
the results were different. This multicentre study recruited
3513 patients hospitalized for CAD. At entry, 1153 patients
had known type 2 diabetes and 97 had newly diagnosed diabe-
tes. Oral glucose tolerance tests (OGTTs) were performed in
the remaining patient. It was revealed that 37.3% had im-
paired glucose regulation (1.4% had isolated IFG, 32.6%
had isolated IGT and 3.3% had combined IFG & IGT) while
26.9% had newly diagnosed DM. This suggests that abnormal
glucose regulation is more common in patients with CAD in
China.9 The large number of patients in the China Heart Sur-
vey and different study protocols might be a cause of divergent
results from ours.Sourij et al., in their study, enrolled 1040 patients undergo-
ing coronary angiography for the evaluation of suspected or
established CAD. In patients without previously established
DM, an OGTT was performed. Prospectively, mortality and
macrovascular events were recorded over a mean follow-up
period of 3.8 years. Patients who had NGT were 394
(37.9%), while 280 patients (27%) had post-challenge hyper-
glycemia including IGT and post-challenge DM. Finally con-
ventional diabetic patients were 366 (35.1%).10
Patients involved in the present study were referred to un-
dergo coronary angiography after having new ischemic event
(ACS) or were chronic IHD patients and referred to do angi-
ography electively. Prediabetes was prevalent among 23.52%
of the new ischemic patients (n= 179) while it prevailed
among 21.34% of the chronic ischemic patients (n= 51) that
was nearly similar although a little bit higher in the acute
group. This might be due to the more stressful condition of pa-
tients in the acute group than those in the chronic group. It
was noticed also that isolated IGT was commoner in both
groups followed by combined IGT & IFG and ﬁnally isolated
IFG.
In contrast to our results, Dotevall et al. found in their
analysis of 4855 patients having CAD within the framework
of the Euro Heart Survey that there were no major differences
in the inﬂuence of diabetes on clinical presentation and symp-
toms between men and women. Differences between patients
with diabetes and those with NGT were usually more apparent
than differences between patients with impaired glucose regu-
lation and normal glucose metabolism, respectively.11 Differ-
ent study populations, and a larger number of subjects with
diabetes in their study, might explain the divergent results be-
tween their study and our one. In China Heart Survey, patients
admitted in acute condition represented 35.13% of the total
number of included patients (n= 1234) while those admitted
electively represented 64.87% of the total number of included
patients (n= 2729). Among the OGTT cohort, it was found
that patients with new impaired glucose regulation among
the acute group represented 39.1% (n= 302) while they repre-
sented 36.4% (n= 542) among elective group patients.9 This
might also be explained by a larger number of patients and dif-
ferent protocols as well as racial reasons.
In the DECODE study, a large cohort study in which a to-
tal of 13 studies from 9 European countries with 7680 men and
9251 women aged 30–89 years were included in the data anal-
ysis, it was found that the prevalence of impaired glucose reg-
ulation (IGR) rose with age in each study. In most of the study
population, the prevalence of IGR was less than 15% at 30–
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The prevalence of IGT increased linearly with age, but the
prevalence of IFG did not.13
In our study, the high risk proﬁle among the prediabetic pa-
tients varied, with hypertension being commoner in predia-
betic females than in prediabetic males (56.4% in females
and 43.6% in males) and higher BMI in prediabetic females
than in prediabetic males (mean of 27.8 in females and mean
of 25.6 in males).
In contrast to our results, The Honolulu Heart Program
found that the rates of hypertension, mean levels of BMI,
waist-to-hip ratio, triglycerides and fasting insulin were higher
in men with IGT and diabetes compared with normal subjects.
Opposite trends were observed for HDL cholesterol. No signif-
icant differences were observed for current smoking and alco-
hol intake. Differences in risk factor levels by glucose tolerance
status remained after adjustment for age, physical activity,
BMI and waist-to-hip ratio.12 It should be noted that the re-
sults were taken and analyzed from only men, who completed
OGTT.12
It should be stressed that in our study, the prediabetic pa-
tients were diagnosed according to both FPG and 2-h PG as
recommended by ESC guidelines on prediabetes, DM and
CVD. 23% was found to have prediabetes, more than half
of which (n= 123) would be missed if only FPG was measured
as the IGT group that was diagnosed according to ESC guide-
lines criteria by isolated elevation of 2-h PG.
This comes in agreement with many studies that justify the
crucial role of 2-h PG in OGTT in diagnosing prediabetic pa-
tients who do not meet the criteria of IFG detected by measur-
ing FPG only. In the Euro Heart Survey prediabetic patients
were detected through OGTT.7 In the Honolulu Heart study,
prediabetic male patients were detected after completing
OGTT.12 In the AusDiab study the diagnostic criteria of
IFG and IGT were based on values from the OGTT.8 In the
China Heart Survey, 87.4% of patients with impaired glucose
regulation would have remained undiagnosed if OGTTs had
not been performed.9 The DECODE study also followed the
same protocol. It was reported that IGT, not IFG, was a
strong predictor of all-cause and cardiovascular mortality,
independent of FBG.13
Diabetes Prevention Program (DPP) study conclusively
showed that people with prediabetes can prevent the develop-
ment of type 2 diabetes by making changes in their diet and
increasing their level of physical activity. They may even be
able to return their blood glucose levels to the normal range.
While the DPP also showed that some medications (like
metformin) may delay the development of diabetes, diet and
exercise worked better. Just 30 min a day of moderate physical
activity, coupled with about a 7% reduction in body weight
produced a 58% reduction in diabetes.14
6. Conclusion
Based on the results of the current study, it can be concluded
that prediabetes (isolated IGT, isolated IFG or combined IGT
& IFG) is prevalent among CAD Egyptian patients at a con-siderable ratio which is why they should be screened for having
it. 2 h post-prandial blood glucose measurement is crucial in
the diagnosis of IGT patients who do not meet the diagnostic
criteria of IFG that is diagnosed by fasting blood glucose.
Once discovered, patients with prediabetes should be advised
to do regular exercise and lose weight to prevent as much as
possible the development of DM.
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